MEDPRO SYSTEMS

Live / Allowed — Publication / registration review complete (as of 09 Sept 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Apr 2026 filing date already counts against anyone who files later.

Record

Serial number
99740809
Mark type
Design + words
Filed
02 Apr 2026
Published for opposition
29 Sept 2026
Attorney of record
Christine Amara

Goods and services

  • Class 042 — Scientific and technological services: (Based on Use) Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing effort (Based on Intent to Use) Software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies to manage healthcare professional engagement activities and workflows; Software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies with healthcare professional fair market value tiering and compensation oversight
  • Class 045 — Legal and security services: Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; Providing online searchable databases and information concerning laws, regulations, and guidance documents for the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and other compliance requirements

Owner

Prosecution history

  • 03 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 02 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 02 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 02 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 18 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 18 Aug 2026 — NON-FINAL ACTION E-MAILED
  • 18 Aug 2026 — NON-FINAL ACTION WRITTEN
  • 12 Aug 2026 — ASSIGNED TO EXAMINER
  • 10 Aug 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
  • 10 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 02 Apr 2026 — APPLICATION FILING RECEIPT MAILED
  • 02 Apr 2026 — NEW APPLICATION ENTERED

View this trademark record on Marksy